Data / Form D filings / AMPLIMED CORP
AMPLIMED CORP: Form D filings
AMPLIMED CORP, a biotechnology company in Tucson, AZ, filed 6 Form D notices with the SEC between 2009 and 2010. The latest, on March 3, 2010, reports $7.1 million sold of a $12 million offering to 11 investors.
Find out what AMPLIMED CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4380 NORTH CAMPBELL AVENUE, SUITE 205, Tucson, AZ, 85718
- Phone
- (520) 529-1000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506, Securities Act section 4(6)
- SEC identifier (CIK)
- 866105
The full lists. Form D filings in Arizona: 953 rows, $47.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 3, 2010 | Amendment | $12,000,000 | $7,142,093 | $4,857,907 | 11 | Aug 17, 2009 | sec.gov |
| Jan 8, 2010 | Amendment | $12,000,000 | $6,604,443 | $5,395,557 | 11 | Aug 17, 2009 | sec.gov |
| Dec 24, 2009 | Amendment | $12,000,000 | $5,649,443 | $6,350,557 | 10 | Aug 17, 2009 | sec.gov |
| Sep 22, 2009 | Amendment | $12,000,000 | $3,919,043 | $8,080,957 | 8 | Aug 17, 2009 | sec.gov |
| Aug 31, 2009 | New notice | $12,000,000 | $3,689,043 | $8,310,957 | 8 | Aug 17, 2009 | sec.gov |
| Apr 30, 2009 | Amendment | $2,500,000 | $1,998,340 | $501,660 | 7 | Nov 21, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Chris Richied | Executive Officer | |
| Randolph T. Steer | Director | |
| Joel A. Smolen | Director | |
| John M. Holliman | Director | |
| Ronald M. Garren | Director | |
| William T. Remers | Executive Officer | |
| Harry A. George | Director | |
| Steve T. Steinman | Executive Officer | |
| Robert T. Dorr | Executive Officer, Director |
Other biotechnology companies in Arizona that filed recently
- Gut-Brain-Axis Therapeutics Inc. $2 million · Oct 27, 2026
- Avery Therapeutics, Inc. $8.5 million · Sep 21, 2026
Every Form D from the week of Mar 1, 2010 · All recent filings in Arizona · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AMPLIMED CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.